1440 related articles for article (PubMed ID: 9295029)
1. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
2. Directed evolution of soluble single-chain human class II MHC molecules.
Esteban O; Zhao H
J Mol Biol; 2004 Jun; 340(1):81-95. PubMed ID: 15184024
[TBL] [Abstract][Full Text] [Related]
3. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
[TBL] [Abstract][Full Text] [Related]
4. V alpha domain modulates the multiple topologies of mouse T cell receptor V beta20/staphylococcal enterotoxins A and E complexes.
Bravo de Alba Y; Marche PN; Cazenave PA; Cloutier I; Sekaly RP; Thibodeau J
Eur J Immunol; 1997 Jan; 27(1):92-9. PubMed ID: 9022003
[TBL] [Abstract][Full Text] [Related]
5. Altered orientation of streptococcal superantigen (SSA) on HLA-DR1 allows unconventional regions to contribute to SSA Vbeta specificity.
Stevens KR; Van M; Lamphear JG; Rich RR
J Immunol; 1996 Dec; 157(11):4970-8. PubMed ID: 8943403
[TBL] [Abstract][Full Text] [Related]
6. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
Karp DR; Teletski CL; Scholl P; Geha R; Long EO
Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
8. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
[TBL] [Abstract][Full Text] [Related]
9. Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain.
Lee L; McHugh L; Ribaudo RK; Kozlowski S; Margulies DH; Mage MG
Eur J Immunol; 1994 Nov; 24(11):2633-9. PubMed ID: 7957555
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins.
Dowd JE; Jenkins RN; Karp DR
J Immunol; 1995 Feb; 154(3):1024-31. PubMed ID: 7822779
[TBL] [Abstract][Full Text] [Related]
11. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
[TBL] [Abstract][Full Text] [Related]
12. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
Barber LD; Lechler RI
J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
[TBL] [Abstract][Full Text] [Related]
13. Production of soluble MHC class II proteins with covalently bound single peptides.
Kozono H; White J; Clements J; Marrack P; Kappler J
Nature; 1994 May; 369(6476):151-4. PubMed ID: 8177320
[TBL] [Abstract][Full Text] [Related]
14. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
15. T cell recognition of allopeptides in context of syngeneic MHC.
Liu Z; Braunstein NS; Suciu-Foca N
J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
[TBL] [Abstract][Full Text] [Related]
16. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
17. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
[TBL] [Abstract][Full Text] [Related]
18. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
[TBL] [Abstract][Full Text] [Related]
19. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
[TBL] [Abstract][Full Text] [Related]
20. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
